| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | MHC class Ib protein binding | 4.79e-06 | 16 | 147 | 4 | GO:0023029 | |
| GeneOntologyMolecularFunction | MHC class Ib receptor activity | 1.00e-05 | 19 | 147 | 4 | GO:0032394 | |
| GeneOntologyMolecularFunction | NAD(P)H oxidase H2O2-forming activity | 8.19e-05 | 12 | 147 | 3 | GO:0016174 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | EPHB3 VN1R2 NPR1 OR2B2 OR8H1 GRIN2D ACVR2A OR2B6 ADGRG4 PTH2R OR52A5 GPR158 SCN7A OR1G1 KIR2DL1 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 OR52A1 EPHB1 | 1.41e-04 | 1353 | 147 | 23 | GO:0004888 |
| GeneOntologyMolecularFunction | glycerol kinase activity | 1.61e-04 | 3 | 147 | 2 | GO:0004370 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.66e-04 | 70 | 147 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.94e-04 | 18 | 147 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | MHC class I receptor activity | 2.94e-04 | 18 | 147 | 3 | GO:0032393 | |
| GeneOntologyMolecularFunction | platelet-activating factor acetyltransferase activity | 3.20e-04 | 4 | 147 | 2 | GO:0047179 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor | 4.07e-04 | 20 | 147 | 3 | GO:0050664 | |
| GeneOntologyMolecularFunction | NADPH oxidase H202-forming activity | 5.31e-04 | 5 | 147 | 2 | GO:0106294 | |
| GeneOntologyMolecularFunction | sodium channel activity | 5.80e-04 | 52 | 147 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | MHC protein binding | 8.79e-04 | 58 | 147 | 4 | GO:0042287 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 9.55e-04 | 153 | 147 | 6 | GO:0008194 | |
| GeneOntologyMolecularFunction | intracellularly cGMP-activated cation channel activity | 1.10e-03 | 7 | 147 | 2 | GO:0005223 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.12e-03 | 28 | 147 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 1.34e-03 | 288 | 147 | 8 | GO:0016757 | |
| GeneOntologyMolecularFunction | immune receptor activity | 1.41e-03 | 165 | 147 | 6 | GO:0140375 | |
| GeneOntologyMolecularFunction | 1-alkyl-2-acetylglycerophosphocholine esterase activity | 1.46e-03 | 8 | 147 | 2 | GO:0003847 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.81e-03 | 33 | 147 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.81e-03 | 118 | 147 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | deaminase activity | 1.98e-03 | 34 | 147 | 3 | GO:0019239 | |
| GeneOntologyMolecularFunction | intracellularly cAMP-activated cation channel activity | 2.33e-03 | 10 | 147 | 2 | GO:0005222 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 2.34e-03 | 36 | 147 | 3 | GO:0016814 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 2.53e-03 | 37 | 147 | 3 | GO:0045505 | |
| GeneOntologyCellularComponent | cullin-RING ubiquitin ligase complex | 1.37e-04 | 212 | 148 | 8 | GO:0031461 | |
| GeneOntologyCellularComponent | 1-alkyl-2-acetylglycerophosphocholine esterase complex | 1.49e-04 | 3 | 148 | 2 | GO:0008247 | |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 3.40e-04 | 47 | 148 | 4 | GO:0031462 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 7.13e-04 | 25 | 148 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | early endosome membrane | 7.99e-04 | 212 | 148 | 7 | GO:0031901 | |
| GeneOntologyCellularComponent | ubiquitin ligase complex | 9.27e-04 | 352 | 148 | 9 | GO:0000151 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.02e-03 | 161 | 148 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | intracellular cyclic nucleotide activated cation channel complex | 1.02e-03 | 7 | 148 | 2 | GO:0017071 | |
| Domain | HEAT_type_2 | 7.06e-06 | 17 | 142 | 4 | IPR021133 | |
| Domain | HELP | 8.46e-06 | 6 | 142 | 3 | PF03451 | |
| Domain | HELP | 8.46e-06 | 6 | 142 | 3 | IPR005108 | |
| Domain | HEAT_REPEAT | 1.53e-05 | 70 | 142 | 6 | PS50077 | |
| Domain | HEAT | 3.12e-05 | 48 | 142 | 5 | PF02985 | |
| Domain | PP2A_A_meta | 5.74e-05 | 2 | 142 | 2 | IPR031090 | |
| Domain | Cytoplasmic_FMR1-int | 5.74e-05 | 2 | 142 | 2 | IPR008081 | |
| Domain | Syntaxin-6_N | 5.74e-05 | 2 | 142 | 2 | IPR015260 | |
| Domain | Syntaxin-6_N | 5.74e-05 | 2 | 142 | 2 | PF09177 | |
| Domain | FragX_IP | 5.74e-05 | 2 | 142 | 2 | PF05994 | |
| Domain | HEAT | 7.85e-05 | 58 | 142 | 5 | IPR000357 | |
| Domain | ig | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 1.04e-04 | 190 | 142 | 8 | PF00047 |
| Domain | Immunoglobulin | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 1.04e-04 | 190 | 142 | 8 | IPR013151 |
| Domain | Dynein_heavy_chain_D4_dom | 1.47e-04 | 14 | 142 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.47e-04 | 14 | 142 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.47e-04 | 14 | 142 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.47e-04 | 14 | 142 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 1.47e-04 | 14 | 142 | 3 | IPR011704 | |
| Domain | MT | 1.47e-04 | 14 | 142 | 3 | PF12777 | |
| Domain | AAA_8 | 1.47e-04 | 14 | 142 | 3 | PF12780 | |
| Domain | APOBEC/CMP_deaminase_Zn-bd | 1.47e-04 | 14 | 142 | 3 | IPR016192 | |
| Domain | AAA_5 | 1.47e-04 | 14 | 142 | 3 | PF07728 | |
| Domain | WD40 | 1.66e-04 | 259 | 142 | 9 | PF00400 | |
| Domain | Carb_kinase_FGGY_CS | 1.71e-04 | 3 | 142 | 2 | IPR018483 | |
| Domain | Lipase_GDSL_2 | 1.71e-04 | 3 | 142 | 2 | PF13472 | |
| Domain | DHC_fam | 1.83e-04 | 15 | 142 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 1.83e-04 | 15 | 142 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.83e-04 | 15 | 142 | 3 | IPR004273 | |
| Domain | WD40 | 2.14e-04 | 268 | 142 | 9 | SM00320 | |
| Domain | Ion_trans_dom | 2.36e-04 | 114 | 142 | 6 | IPR005821 | |
| Domain | Ion_trans | 2.36e-04 | 114 | 142 | 6 | PF00520 | |
| Domain | WD40_repeat | 2.39e-04 | 272 | 142 | 9 | IPR001680 | |
| Domain | CYT_DCMP_DEAMINASES_1 | 2.71e-04 | 17 | 142 | 3 | PS00903 | |
| Domain | CMP_dCMP_Zn-bd | 2.71e-04 | 17 | 142 | 3 | IPR002125 | |
| Domain | Cytidine_deaminase-like | 2.71e-04 | 17 | 142 | 3 | IPR016193 | |
| Domain | WD_REPEATS_1 | 2.81e-04 | 278 | 142 | 9 | PS00678 | |
| Domain | WD_REPEATS_2 | 2.88e-04 | 279 | 142 | 9 | PS50082 | |
| Domain | WD_REPEATS_REGION | 2.88e-04 | 279 | 142 | 9 | PS50294 | |
| Domain | DUF1394 | 3.41e-04 | 4 | 142 | 2 | IPR009828 | |
| Domain | DUF1394 | 3.41e-04 | 4 | 142 | 2 | PF07159 | |
| Domain | Glycerol_kin | 3.41e-04 | 4 | 142 | 2 | IPR005999 | |
| Domain | Fd_Rdtase_FAD-bd | 3.81e-04 | 19 | 142 | 3 | IPR017927 | |
| Domain | FAD_FR | 3.81e-04 | 19 | 142 | 3 | PS51384 | |
| Domain | Riboflavin_synthase-like_b-brl | 3.81e-04 | 19 | 142 | 3 | IPR017938 | |
| Domain | WD40_repeat_dom | 4.54e-04 | 297 | 142 | 9 | IPR017986 | |
| Domain | FGGY_KINASES_1 | 5.65e-04 | 5 | 142 | 2 | PS00933 | |
| Domain | Carb_kinase_FGGY_C | 5.65e-04 | 5 | 142 | 2 | IPR018485 | |
| Domain | Lipase_GDSL | 5.65e-04 | 5 | 142 | 2 | PF00657 | |
| Domain | GDSL | 5.65e-04 | 5 | 142 | 2 | IPR001087 | |
| Domain | FGGY_KINASES_2 | 5.65e-04 | 5 | 142 | 2 | PS00445 | |
| Domain | LIPASE_GDSL_SER | 5.65e-04 | 5 | 142 | 2 | PS01098 | |
| Domain | Quinoprotein_ADH-like_supfam | 7.02e-04 | 53 | 142 | 4 | IPR011047 | |
| Domain | AAA | 8.20e-04 | 144 | 142 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 8.20e-04 | 144 | 142 | 6 | IPR003593 | |
| Domain | Carb_kinase_FGGY_N | 8.44e-04 | 6 | 142 | 2 | IPR018484 | |
| Domain | Haem_d1 | 8.44e-04 | 6 | 142 | 2 | IPR011048 | |
| Domain | FGGY_C | 8.44e-04 | 6 | 142 | 2 | PF02782 | |
| Domain | - | 1.03e-03 | 333 | 142 | 9 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 1.07e-03 | 335 | 142 | 9 | IPR015943 | |
| Domain | Carb_kinase_FGGY | 1.18e-03 | 7 | 142 | 2 | IPR000577 | |
| Domain | FGGY_N | 1.18e-03 | 7 | 142 | 2 | PF00370 | |
| Domain | NAD_binding_6 | 1.18e-03 | 7 | 142 | 2 | PF08030 | |
| Domain | FAD_binding_8 | 1.18e-03 | 7 | 142 | 2 | PF08022 | |
| Domain | FAD-bd_8 | 1.18e-03 | 7 | 142 | 2 | IPR013112 | |
| Domain | Fe_red_NAD-bd_6 | 1.18e-03 | 7 | 142 | 2 | IPR013121 | |
| Domain | - | 1.18e-03 | 7 | 142 | 2 | 3.40.50.1110 | |
| Domain | SGNH_hydro | 1.56e-03 | 8 | 142 | 2 | IPR013830 | |
| Domain | DHC_N1 | 1.56e-03 | 8 | 142 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.56e-03 | 8 | 142 | 2 | IPR013594 | |
| Domain | - | 1.56e-03 | 222 | 142 | 7 | 1.25.10.10 | |
| Domain | WD40_repeat_CS | 1.60e-03 | 164 | 142 | 6 | IPR019775 | |
| Domain | TPR_REGION | 1.65e-03 | 165 | 142 | 6 | PS50293 | |
| Domain | TPR | 1.65e-03 | 165 | 142 | 6 | PS50005 | |
| Domain | Na_channel_asu | 2.48e-03 | 10 | 142 | 2 | IPR001696 | |
| Domain | An_peroxidase | 2.48e-03 | 10 | 142 | 2 | PF03098 | |
| Domain | Na_trans_assoc | 2.48e-03 | 10 | 142 | 2 | IPR010526 | |
| Domain | Haem_peroxidase_animal | 2.48e-03 | 10 | 142 | 2 | IPR019791 | |
| Domain | Na_trans_assoc | 2.48e-03 | 10 | 142 | 2 | PF06512 | |
| Domain | Haem_peroxidase | 2.48e-03 | 10 | 142 | 2 | IPR010255 | |
| Domain | PEROXIDASE_3 | 2.48e-03 | 10 | 142 | 2 | PS50292 | |
| Domain | - | 2.48e-03 | 10 | 142 | 2 | 1.10.640.10 | |
| Domain | Pkinase_Tyr | 3.07e-03 | 129 | 142 | 5 | PF07714 | |
| Domain | Ferric_reduct | 3.60e-03 | 12 | 142 | 2 | PF01794 | |
| Domain | GrpE_coiled_coil | 3.60e-03 | 12 | 142 | 2 | IPR013805 | |
| Domain | Quinoprot_gluc/sorb_DH | 3.60e-03 | 12 | 142 | 2 | IPR011041 | |
| Domain | APOBEC_N | 3.60e-03 | 12 | 142 | 2 | PF08210 | |
| Domain | APOBEC_N | 3.60e-03 | 12 | 142 | 2 | IPR013158 | |
| Domain | Fe3_Rdtase_TM_dom | 3.60e-03 | 12 | 142 | 2 | IPR013130 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 4.09e-03 | 138 | 142 | 5 | IPR001245 | |
| Domain | ARM-type_fold | 4.45e-03 | 339 | 142 | 8 | IPR016024 | |
| Domain | Tyr_kinase_cat_dom | 4.56e-03 | 88 | 142 | 4 | IPR020635 | |
| Domain | TyrKc | 4.56e-03 | 88 | 142 | 4 | SM00219 | |
| Domain | ARM-like | 4.64e-03 | 270 | 142 | 7 | IPR011989 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 4.92e-03 | 14 | 142 | 2 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 4.92e-03 | 14 | 142 | 2 | PS00790 | |
| Domain | VitD_rcpt | 4.92e-03 | 14 | 142 | 2 | IPR000324 | |
| Domain | Tyr_kinase_rcpt_V_CS | 4.92e-03 | 14 | 142 | 2 | IPR001426 | |
| Domain | EphA2_TM | 4.92e-03 | 14 | 142 | 2 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 4.92e-03 | 14 | 142 | 2 | IPR001090 | |
| Domain | Eph_TM | 4.92e-03 | 14 | 142 | 2 | IPR027936 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 4.86e-06 | 88 | 108 | 7 | M16004 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 8.65e-05 | 137 | 108 | 7 | M5669 | |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 4.83e-17 | 12 | 150 | 8 | 20137308 | |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 2.91e-16 | 14 | 150 | 8 | 19875891 | |
| Pubmed | Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 2.91e-16 | 14 | 150 | 8 | 15896204 |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 6.22e-16 | 15 | 150 | 8 | 20082646 | |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 6.22e-16 | 15 | 150 | 8 | 20356536 | |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 6.22e-16 | 15 | 150 | 8 | 19926642 | |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 6.22e-16 | 15 | 150 | 8 | 20643584 | |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 6.22e-16 | 15 | 150 | 8 | 19326408 | |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 1.24e-15 | 16 | 150 | 8 | 19897003 | |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 1.24e-15 | 16 | 150 | 8 | 19000141 | |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 1.24e-15 | 16 | 150 | 8 | 20670355 | |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 1.24e-15 | 16 | 150 | 8 | 18668235 | |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 1.24e-15 | 16 | 150 | 8 | 19309280 | |
| Pubmed | Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage. | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 1.24e-15 | 16 | 150 | 8 | 19527230 |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 1.24e-15 | 16 | 150 | 8 | 20652381 | |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 1.24e-15 | 16 | 150 | 8 | 19279038 | |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 1.24e-15 | 16 | 150 | 8 | 17868255 | |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 1.24e-15 | 16 | 150 | 8 | 18643961 | |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 1.24e-15 | 16 | 150 | 8 | 20331834 | |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 1.24e-15 | 16 | 150 | 8 | 20210919 | |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 2.33e-15 | 17 | 150 | 8 | 19968064 | |
| Pubmed | Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 2.33e-15 | 17 | 150 | 8 | 20878400 |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 2.33e-15 | 17 | 150 | 8 | 20650299 | |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 2.33e-15 | 17 | 150 | 8 | 19032228 | |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 2.33e-15 | 17 | 150 | 8 | 20173792 | |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 2.33e-15 | 17 | 150 | 8 | 20483367 | |
| Pubmed | [Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese]. | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 2.33e-15 | 17 | 150 | 8 | 19218127 |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 2.33e-15 | 17 | 150 | 8 | 19450876 | |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 2.33e-15 | 17 | 150 | 8 | 19761533 | |
| Pubmed | Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis. | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 4.18e-15 | 18 | 150 | 8 | 19630074 |
| Pubmed | Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians. | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 4.18e-15 | 18 | 150 | 8 | 19046302 |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 4.18e-15 | 18 | 150 | 8 | 20580654 | |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 4.18e-15 | 18 | 150 | 8 | 20519398 | |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 4.18e-15 | 18 | 150 | 8 | 19846535 | |
| Pubmed | KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease. | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 7.20e-15 | 19 | 150 | 8 | 18571006 |
| Pubmed | Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil. | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 7.20e-15 | 19 | 150 | 8 | 18778326 |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 7.20e-15 | 19 | 150 | 8 | 20600442 | |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 7.20e-15 | 19 | 150 | 8 | 18848853 | |
| Pubmed | [Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients]. | 7.84e-15 | 11 | 150 | 7 | 19664392 | |
| Pubmed | Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay. | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 1.20e-14 | 20 | 150 | 8 | 20193031 |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 1.20e-14 | 20 | 150 | 8 | 20426625 | |
| Pubmed | 1.87e-14 | 12 | 150 | 7 | 20371502 | ||
| Pubmed | 1.87e-14 | 12 | 150 | 7 | 19936734 | ||
| Pubmed | Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome. | 1.87e-14 | 12 | 150 | 7 | 19181658 | |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 1.92e-14 | 21 | 150 | 8 | 19861144 | |
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 3.01e-14 | 22 | 150 | 8 | 20492596 | |
| Pubmed | 4.05e-14 | 13 | 150 | 7 | 19934297 | ||
| Pubmed | 4.05e-14 | 13 | 150 | 7 | 19120281 | ||
| Pubmed | 4.05e-14 | 13 | 150 | 7 | 18687225 | ||
| Pubmed | 8.06e-14 | 14 | 150 | 7 | 19489269 | ||
| Pubmed | Multiple sclerosis associates with LILRA3 deletion in Spanish patients. | 8.06e-14 | 14 | 150 | 7 | 19421224 | |
| Pubmed | 8.06e-14 | 14 | 150 | 7 | 18945962 | ||
| Pubmed | 1.51e-13 | 15 | 150 | 7 | 19850842 | ||
| Pubmed | Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma. | 1.51e-13 | 15 | 150 | 7 | 20207982 | |
| Pubmed | 1.51e-13 | 15 | 150 | 7 | 19493232 | ||
| Pubmed | KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations. | 1.51e-13 | 15 | 150 | 7 | 17498266 | |
| Pubmed | 1.62e-13 | 8 | 150 | 6 | 9430221 | ||
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population]. | 2.67e-13 | 16 | 150 | 7 | 16403292 | |
| Pubmed | Immunogenetic characteristics of patients with autoimmune gastritis. | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 3.94e-13 | 29 | 150 | 8 | 20082482 |
| Pubmed | 4.52e-13 | 17 | 150 | 7 | 20173784 | ||
| Pubmed | 4.52e-13 | 17 | 150 | 7 | 19169284 | ||
| Pubmed | 4.84e-13 | 9 | 150 | 6 | 7749980 | ||
| Pubmed | Alternatively spliced forms of human killer inhibitory receptors. | 4.84e-13 | 9 | 150 | 6 | 8662091 | |
| Pubmed | 4.84e-13 | 9 | 150 | 6 | 18340360 | ||
| Pubmed | 7.37e-13 | 18 | 150 | 7 | 20200544 | ||
| Pubmed | 7.37e-13 | 18 | 150 | 7 | 20210918 | ||
| Pubmed | 1.20e-12 | 10 | 150 | 6 | 12559621 | ||
| Pubmed | 1.20e-12 | 10 | 150 | 6 | 21206914 | ||
| Pubmed | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 2.11e-12 | 35 | 150 | 8 | 19683555 | |
| Pubmed | 2.64e-12 | 11 | 150 | 6 | 18830515 | ||
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia]. | 5.26e-12 | 12 | 150 | 6 | 17490516 | |
| Pubmed | 2.91e-11 | 7 | 150 | 5 | 14607943 | ||
| Pubmed | 2.91e-11 | 7 | 150 | 5 | 9430220 | ||
| Pubmed | 7.73e-11 | 8 | 150 | 5 | 18681957 | ||
| Pubmed | 1.66e-09 | 5 | 150 | 4 | 19410616 | ||
| Pubmed | Association of killer cell immunoglobulin-like receptor genotypes with microscopic polyangiitis. | 1.66e-09 | 5 | 150 | 4 | 16508981 | |
| Pubmed | 4.95e-09 | 6 | 150 | 4 | 20528243 | ||
| Pubmed | 1.15e-08 | 7 | 150 | 4 | 12618911 | ||
| Pubmed | 1.15e-08 | 7 | 150 | 4 | 26928464 | ||
| Pubmed | Expression of a killer cell receptor-like gene in plastic regions of the central nervous system. | 1.15e-08 | 7 | 150 | 4 | 15748957 | |
| Pubmed | 2.30e-08 | 8 | 150 | 4 | 15730517 | ||
| Pubmed | 4.12e-08 | 9 | 150 | 4 | 18074414 | ||
| Pubmed | 4.12e-08 | 9 | 150 | 4 | 18186800 | ||
| Pubmed | Activating KIR/HLA-I combinations as a risk factor of adult B-ALL. | 7.86e-08 | 3 | 150 | 3 | 38262874 | |
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 8765026 | ||
| Pubmed | Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. | 7.86e-08 | 3 | 150 | 3 | 11859120 | |
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 19500138 | ||
| Pubmed | Association of killer cell immunoglobulin-like receptors with pulmonary tuberculosis in Chinese Han. | 7.86e-08 | 3 | 150 | 3 | 22653583 | |
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 29408295 | ||
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 19859704 | ||
| Pubmed | Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis. | 7.86e-08 | 3 | 150 | 3 | 19019897 | |
| Pubmed | Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1. | 3.14e-07 | 4 | 150 | 3 | 27455421 | |
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 18632158 | ||
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 25253288 | ||
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 18718052 | ||
| Pubmed | Activating KIR genes are associated with ankylosing spondylitis in Asian populations. | 3.14e-07 | 4 | 150 | 3 | 18638658 | |
| Pubmed | Recombinant structures expand and contract inter and intragenic diversification at the KIR locus. | 3.14e-07 | 4 | 150 | 3 | 23394822 | |
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 23354323 | ||
| Pubmed | A role for KIR gene variants other than KIR2DS1 in conferring susceptibility to psoriasis. | 3.14e-07 | 4 | 150 | 3 | 16829306 | |
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 16698429 | ||
| Interaction | KIR2DL2 interactions | 1.79e-08 | 13 | 139 | 5 | int:KIR2DL2 | |
| Interaction | KIR2DL1 interactions | 1.26e-06 | 28 | 139 | 5 | int:KIR2DL1 | |
| Interaction | AMZ1 interactions | 1.27e-05 | 44 | 139 | 5 | int:AMZ1 | |
| Cytoband | 19q13.4 | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 2.31e-10 | 79 | 150 | 8 | 19q13.4 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | VN1R2 KLK15 TMEM150B EML2 GRIN2D PPP2R1A ALDH16A1 PAFAH1B3 KIR2DL1 KIR2DS4 KIR3DL1 ZNF418 KIR3DL2 | 1.58e-04 | 1192 | 150 | 13 | chr19q13 |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 KIR3DS1 | 4.45e-14 | 18 | 106 | 8 | 620 |
| GeneFamily | WD repeat domain containing | 2.37e-05 | 262 | 106 | 9 | 362 | |
| GeneFamily | Protein phosphatase 2 scaffold subunits|STRIPAK complex | 3.41e-05 | 2 | 106 | 2 | 1266 | |
| GeneFamily | Dyneins, axonemal | 1.25e-04 | 17 | 106 | 3 | 536 | |
| GeneFamily | Glycerol kinases | 5.03e-04 | 6 | 106 | 2 | 568 | |
| GeneFamily | Cyclic nucleotide gated channels | 1.49e-03 | 10 | 106 | 2 | 250 | |
| GeneFamily | Apolipoprotein B mRNA editing enzyme catalytic subunits | 2.16e-03 | 12 | 106 | 2 | 406 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 2.96e-03 | 14 | 106 | 2 | 1095 | |
| GeneFamily | Syntaxins | 3.87e-03 | 16 | 106 | 2 | 818 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.62e-07 | 194 | 146 | 8 | ae5357e2a276473cde1fc8c43acaf9f69da35fd7 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.62e-07 | 194 | 146 | 8 | 3a0b8b5d0354c43da57bb951cd8ba878363c3de5 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 6.85e-07 | 151 | 146 | 7 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | 368C-Lymphocytic-NK_cells|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.90e-07 | 157 | 146 | 7 | ef5c0ace4cd500b6cc50fb7076298f3d3543b40c | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 169 | 146 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.76e-06 | 195 | 146 | 7 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | CV-Moderate-1|CV / Virus stimulation, Condition and Cluster | 4.02e-06 | 197 | 146 | 7 | e3d00d850b4d191f9592ef993c0eaadfe5710b5f | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 4.16e-06 | 198 | 146 | 7 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.30e-06 | 199 | 146 | 7 | eb05ccae5187e4701bbbe6d714a6d2808fbcf306 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-NK|Influenza_Severe / Disease, condition lineage and cell class | 4.44e-06 | 200 | 146 | 7 | 04ac14414d550b14dc46d682e7af9dd43982211a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic-Neutrophil-Neu_c3-CST7|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.12e-06 | 144 | 146 | 6 | b638398f559e7fd9d4294d1c830beeb20f905960 | |
| ToppCell | droplet-Heart-4Chambers-21m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 156 | 146 | 6 | 5d97755db872d51522f6412a93704f3c79a084cd | |
| ToppCell | NS-critical-d_0-4-Epithelial-unknown_epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.82e-05 | 166 | 146 | 6 | dd02bbe4af609c6348dc92417254f4740f2900a8 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 1.89e-05 | 167 | 146 | 6 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.95e-05 | 168 | 146 | 6 | 9a8709d34865cfa668d8f3335dc34fc86fc32482 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-05 | 169 | 146 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.09e-05 | 170 | 146 | 6 | 07b561cd9c528bc8444c9385e1de621eee7b697e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-05 | 171 | 146 | 6 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 174 | 146 | 6 | ff13a5c55d18b951315908f33cb47c7f9cb901bf | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.46e-05 | 175 | 146 | 6 | bb898796662b97f7459b7dda7cecf6a9bde8b055 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.06e-05 | 182 | 146 | 6 | 57f8b8d7b132f3ad6f2b1e79c3812fe938657d2c | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 3.16e-05 | 183 | 146 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.35e-05 | 185 | 146 | 6 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.56e-05 | 187 | 146 | 6 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | control-Myeloid-Neutrophils_4|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.67e-05 | 188 | 146 | 6 | 22d76c222fb0e3da08e10191af0090f14e03f2ad | |
| ToppCell | Control|World / Disease state, Lineage and Cell class | 3.78e-05 | 189 | 146 | 6 | fb8dddd3b901081c6bb9ed6f32dafc5cce5f30be | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.89e-05 | 190 | 146 | 6 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.89e-05 | 190 | 146 | 6 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | control-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.01e-05 | 191 | 146 | 6 | db1b3cd07d7d190155b2d14e82e1d124975fbd0b | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.01e-05 | 191 | 146 | 6 | 355f5bcb220d917163833dead0050fc756c7b260 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.01e-05 | 191 | 146 | 6 | 337d7d7b89fe370e1fe005b9daad76c5dc3b8444 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.01e-05 | 191 | 146 | 6 | 2bd4ba4aaa0f4885079516156b409df527ab22f4 | |
| ToppCell | Ciliated-cil-3|World / Class top | 4.13e-05 | 192 | 146 | 6 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.25e-05 | 193 | 146 | 6 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-05 | 193 | 146 | 6 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.25e-05 | 193 | 146 | 6 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-05 | 193 | 146 | 6 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | mild-Myeloid-Neutrophils_1|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.37e-05 | 194 | 146 | 6 | ccd911ce3251cd1c60f1fb2ce00650fbe7a379bb | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-NK_CD16|bone_marrow / Manually curated celltypes from each tissue | 4.37e-05 | 194 | 146 | 6 | 7773501e076d470158dbc1d7f10c67152b326eb7 | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK-NK_CD16|Lung / Manually curated celltypes from each tissue | 4.50e-05 | 195 | 146 | 6 | e91e7f89163c615b706f3297b641b1e4c966f5e6 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.50e-05 | 195 | 146 | 6 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.50e-05 | 195 | 146 | 6 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK|Lung / Manually curated celltypes from each tissue | 4.50e-05 | 195 | 146 | 6 | a5a10ef9254c266316e5591bec19e159cc3caead | |
| ToppCell | control-Myeloid-Neutrophils_1|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.63e-05 | 196 | 146 | 6 | 9c8623232c47af5de9f360fd5c5113362e37c6c9 | |
| ToppCell | CV-Moderate-1|Moderate / Virus stimulation, Condition and Cluster | 4.63e-05 | 196 | 146 | 6 | b50cfcd87c5b67806450cb8b3c6860ab97f6d3b1 | |
| ToppCell | Mild-CD8+_T_activated|World / Disease group and Cell class | 4.63e-05 | 196 | 146 | 6 | 79632190e44fcef9d7c11d9b9e37f2ebf0e6e255 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.76e-05 | 197 | 146 | 6 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | Influenza_Severe-NK|Influenza_Severe / Disease group and Cell class | 4.76e-05 | 197 | 146 | 6 | d0f58ee4c02573d214deb210bb7efd3d6118f267 | |
| ToppCell | Severe_COVID-19-T/NK-NK|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 4.76e-05 | 197 | 146 | 6 | cc20162892b59e48653981f91fc9a0c27064444d | |
| ToppCell | control-Myeloid-Neutrophils_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.76e-05 | 197 | 146 | 6 | 8819db1550bf14566c6d33d97f7f83419e867ace | |
| ToppCell | COVID-19_Severe-NK_activated|World / disease group, cell group and cell class | 4.76e-05 | 197 | 146 | 6 | a60db36d1a192998e3ded63e0c7c08d41689f95f | |
| ToppCell | mild-Lymphocytic-NK_cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.90e-05 | 198 | 146 | 6 | dce3c008757786aa6bd4a869456b76b4cbbb1d5b | |
| ToppCell | mild-Lymphocytic-NK_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.90e-05 | 198 | 146 | 6 | 1d20fc9948965de52a98f758035edfdd12cafc5f | |
| ToppCell | Mild-CD8+_T_activated|Mild / Disease group and Cell class | 4.90e-05 | 198 | 146 | 6 | ceac1b51bacfd0dd7fe7c6a666f7927055e1f380 | |
| ToppCell | severe_COVID-19-NK|World / disease group, cell group and cell class (v2) | 4.90e-05 | 198 | 146 | 6 | 36b1370ef68c4bbe0268933a6ef5e6022d992bdf | |
| ToppCell | CV-Mild-1|CV / Virus stimulation, Condition and Cluster | 4.90e-05 | 198 | 146 | 6 | 4b078714c49e7befb7b113d72485e712236d35fa | |
| ToppCell | mild-B_memory|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.03e-05 | 199 | 146 | 6 | e6ac9a0959b0de2c6a99298feb7715aa80ade1dd | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.03e-05 | 199 | 146 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-NK_activated|COVID-19_Severe / Disease group, lineage and cell class | 5.03e-05 | 199 | 146 | 6 | edf5f80b4c299e6bf462675f2cd3329d86c923d8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.03e-05 | 199 | 146 | 6 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.03e-05 | 199 | 146 | 6 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | COVID-19_Moderate-NK|World / disease group, cell group and cell class | 5.03e-05 | 199 | 146 | 6 | c41b67b760831c7d5e19fabcc932a056dc560f93 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.03e-05 | 199 | 146 | 6 | b03539908131308d7bf5036e78c4c840a6a79a17 | |
| ToppCell | COVID-19_Moderate-NK|COVID-19_Moderate / disease group, cell group and cell class | 5.03e-05 | 199 | 146 | 6 | e0e83ba511957be9ad3413460dcb6b7d7b65dd18 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.03e-05 | 199 | 146 | 6 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.03e-05 | 199 | 146 | 6 | 4820f5bcd7bc34c2ebf6a3422cc8eb383a3b5a4e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.03e-05 | 199 | 146 | 6 | 10c8729b779073c3bf808e85958d59147f0be5c5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.03e-05 | 199 | 146 | 6 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.03e-05 | 199 | 146 | 6 | 867fd292f3879982422e840e087bfdb3b21a8715 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.03e-05 | 199 | 146 | 6 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.03e-05 | 199 | 146 | 6 | 7d071c88a003babf6dbdb84dde561fc03c92f375 | |
| ToppCell | Control-Lymphoid_T/NK-NK|Control / Disease group, lineage and cell class | 5.03e-05 | 199 | 146 | 6 | 94b2693a8378b9b2c58c6aebb2c6658d75b2e3de | |
| ToppCell | (10)_Ciliated|World / shred by cell type by condition | 5.18e-05 | 200 | 146 | 6 | 1b6a8025bd2746b626040058c122b1be3ab2fa61 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.18e-05 | 200 | 146 | 6 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-NK|IIF / Disease, condition lineage and cell class | 5.18e-05 | 200 | 146 | 6 | 4f889cc5ab76a128fd781d927b0d8368f4f927b7 | |
| ToppCell | Biopsy_Control_(H.)-Immune-NK_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 5.18e-05 | 200 | 146 | 6 | c93393d52ed1c238d539f254fd2a95eb101a6f65 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.18e-05 | 200 | 146 | 6 | 0b65855617fb7730de48facf411e2a8980f9f780 | |
| ToppCell | severe-NK|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.18e-05 | 200 | 146 | 6 | 64e8a6c36e0c654b7b2416c9f19b9058215222b1 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK|Control / Disease, condition lineage and cell class | 5.18e-05 | 200 | 146 | 6 | c64c27dbf4df42ca2ad2bd94b50fab87b4050ef3 | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 5.18e-05 | 200 | 146 | 6 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-NK-ILC|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.18e-05 | 200 | 146 | 6 | 4150170a135c37a7932bfb61acedac22dad01a3e | |
| ToppCell | mild-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.18e-05 | 200 | 146 | 6 | fe815824e9e4be3f3db73610e3814a7fd533da65 | |
| ToppCell | Biopsy_Other_PF-Immune-NK_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 5.18e-05 | 200 | 146 | 6 | 418d665b8431697fc9e516258c9fe374257750d9 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.18e-05 | 200 | 146 | 6 | b4d956067eb292cf2855c674d1eb05a5f2d988f7 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.18e-05 | 200 | 146 | 6 | d1cfc4ef6ae75c486427e393d98b84a2a7ec67fe | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.18e-05 | 200 | 146 | 6 | 0a6fc7eff94e2f71af9f31a01779aafd2f4a6699 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-NK|URO / Disease, condition lineage and cell class | 5.18e-05 | 200 | 146 | 6 | 741c7bad606c7e4d7db57d89aaf4dcf4232fa82a | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-NK_activated|COVID-19_Severe / Disease, condition lineage and cell class | 5.18e-05 | 200 | 146 | 6 | 6a77f9643646bafc1157bf1fc1e4c614860ee642 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 5.18e-05 | 200 | 146 | 6 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Biopsy_IPF-Immune-NK_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 5.18e-05 | 200 | 146 | 6 | aea5592a18e25e6179d3201785ddf1e7804d286b | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 5.18e-05 | 200 | 146 | 6 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-NK-ILC|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.18e-05 | 200 | 146 | 6 | c09bb5c994f098d86e873bd3f1d911b02563e6e2 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Cilia-bearing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 5.18e-05 | 200 | 146 | 6 | 177f9ad8dd8635394c575a2b30140184df0bd51e | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-immature_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.46e-05 | 132 | 146 | 5 | 9936078c328b1e1d59f9dfdd69d36926a0cdaf0d | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.53e-05 | 139 | 146 | 5 | 408bc31aa5e1c2b379f79198fe8b5411f8d7bd08 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sfrp2-Inhibitory_Neuron.Gad1Gad2_Id2.Sfrp2_(Interneuron,_Neurogliaform1)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.73e-05 | 73 | 146 | 4 | cc89c94a3768b02036757dea86989d9284b214b9 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sfrp2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.73e-05 | 73 | 146 | 4 | 6f28d52700bab981c8a3664ba4762f3572f7e788 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sfrp2-Inhibitory_Neuron.Gad1Gad2_Id2.Sfrp2_(Interneuron,_Neurogliaform1)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.73e-05 | 73 | 146 | 4 | ae80fcf3544c18fe0318a8311e96f2448f7cb03c | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2-Chat.Synpr-Slc5a7_(Neuron.Gad1Gad2-Chat.Synpr-Slc5a7)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.03e-04 | 74 | 146 | 4 | 0d705c42e7741b861ba5a9f1af83b2c5c6f23fb6 | |
| ToppCell | (6)_Macrophage-(60)_Macrophage|(6)_Macrophage / shred on Cell_type and subtype | 1.03e-04 | 74 | 146 | 4 | 356978d2ee61e7042d7a9ad3bc744d3e7a7f76c0 | |
| Drug | D-Au | SLC28A1 KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DL2 | 3.80e-08 | 77 | 148 | 8 | CID000277822 |
| Drug | Aa1 | 1.17e-06 | 83 | 148 | 7 | CID009549188 | |
| Disease | retinitis pigmentosa (is_implicated_in) | 1.41e-06 | 41 | 139 | 5 | DOID:10584 (is_implicated_in) | |
| Disease | chromosome 15q11.2 deletion syndrome (implicated_via_orthology) | 6.59e-05 | 3 | 139 | 2 | DOID:0060393 (implicated_via_orthology) | |
| Disease | Zellweger syndrome (is_implicated_in) | 6.59e-05 | 3 | 139 | 2 | DOID:905 (is_implicated_in) | |
| Disease | glycerol kinase deficiency (implicated_via_orthology) | 6.59e-05 | 3 | 139 | 2 | DOID:0060363 (implicated_via_orthology) | |
| Disease | 2'-O-methyluridine measurement | 2.18e-04 | 5 | 139 | 2 | EFO_0800636 | |
| Disease | Retinitis pigmentosa | 4.20e-04 | 74 | 139 | 4 | cv:C0035334 | |
| Disease | total iron binding capacity | 5.13e-04 | 78 | 139 | 4 | EFO_0006334 | |
| Disease | Disorder of eye | 5.21e-04 | 212 | 139 | 6 | C0015397 | |
| Disease | serum iron measurement | 7.42e-04 | 86 | 139 | 4 | EFO_0006332 | |
| Disease | acquired immunodeficiency syndrome (is_implicated_in) | 7.76e-04 | 9 | 139 | 2 | DOID:635 (is_implicated_in) | |
| Disease | spondylosis | 8.90e-04 | 40 | 139 | 3 | MONDO_0002253 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 9.67e-04 | 10 | 139 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 9.67e-04 | 10 | 139 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | RETINITIS PIGMENTOSA | 9.67e-04 | 10 | 139 | 2 | 268000 | |
| Disease | Paranoia | 1.18e-03 | 11 | 139 | 2 | C1456784 | |
| Disease | Gastric Adenocarcinoma | 1.26e-03 | 45 | 139 | 3 | C0278701 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.41e-03 | 12 | 139 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | killer cell immunoglobulin-like receptor 2DL4 measurement | 1.41e-03 | 12 | 139 | 2 | EFO_0008197 | |
| Disease | Retinitis Pigmentosa | 1.51e-03 | 104 | 139 | 4 | C0035334 | |
| Disease | Ciliopathies | 1.85e-03 | 110 | 139 | 4 | C4277690 | |
| Disease | susceptibility to bacterial meningitis measurement | 1.91e-03 | 52 | 139 | 3 | EFO_0008411 | |
| Disease | hepcidin:transferrin saturation ratio | 2.22e-03 | 15 | 139 | 2 | EFO_0007902 | |
| Disease | transferrin saturation measurement | 2.53e-03 | 16 | 139 | 2 | EFO_0006333 | |
| Disease | response to acetylsalicylate | 2.53e-03 | 16 | 139 | 2 | GO_1903492 | |
| Disease | serum hepcidin measurement | 3.21e-03 | 18 | 139 | 2 | EFO_0004504 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EKLNSLCMAWLVDHV | 441 | P30153 | |
| LCMAWLVDHVYAIRE | 446 | P30153 | |
| NSLCMAWLVDHVYAI | 456 | P30154 | |
| DDRQDFCRQLHWAMD | 166 | A9YTQ3 | |
| EHEKRCWSVDFNLMD | 511 | Q8NHY2 | |
| IEHICTSDNWMDRFR | 76 | P56851 | |
| RNESWLCFTMEVTKH | 226 | Q96AK3 | |
| LTSMRVHEVAEFWCD | 76 | Q9NZN9 | |
| HAEMVAIDQVLDWCR | 71 | Q7Z6V5 | |
| EHERWLAMCIQALQR | 406 | Q400G9 | |
| RCLALHQDVQAMWYF | 731 | Q8IZ83 | |
| HILCFAWQDRMTAEL | 776 | P78363 | |
| AACVLFTVMDHDWLS | 1096 | O94812 | |
| QLWDHILENEEFMKC | 186 | Q8IZF6 | |
| ANEHLLCSELMRWII | 126 | Q8N7X0 | |
| CYEVERMHNDTWVLL | 221 | Q9HC16 | |
| WNELCHIAETMARGL | 286 | P27037 | |
| LREFIRMHCTSNPDW | 461 | Q6ZU67 | |
| CLQLCTLHDEMLHWF | 146 | Q92624 | |
| TLHDEMLHWFRAVEC | 151 | Q92624 | |
| SHLEELGLLMQRCWA | 771 | P16066 | |
| QDLCELHMVEWRTCL | 81 | Q5VUD6 | |
| VIECTQDNRSLLHMW | 871 | Q9Y485 | |
| HREADFFWSLCTADM | 396 | O15519 | |
| RGECHKVLEMFDWNL | 1006 | Q07912 | |
| IGRHWNEQMLDIACR | 481 | Q06278 | |
| SEARCLELHMEIDWI | 381 | Q6P1R3 | |
| ICESASRLLFLSMHW | 386 | P49116 | |
| HIWTLFENFTLDMAR | 1436 | Q14573 | |
| ILQCWSDVMFEHFFL | 141 | P43630 | |
| DSLVQLMHQCEIWRE | 46 | Q15102 | |
| IRNHLQMDDITCYWE | 346 | Q8NBL1 | |
| VDECVEFHRLWSAMQ | 1121 | Q7L576 | |
| AALHQLMLDCWQKDR | 851 | P54762 | |
| MHQRLCLQLAAASWV | 136 | P58173 | |
| ILQCWSDVMFEHFLL | 46 | P43632 | |
| TEVPAMREARAHFWC | 406 | Q8N239 | |
| HVLALDECQNLMFWT | 2321 | Q9NZR2 | |
| MLLPCHWVLDATFSD | 1 | Q8TD91 | |
| MLFNIHSLEWDKQLC | 206 | Q14409 | |
| DHLIFNMCLIDRWDY | 566 | Q5T848 | |
| DFMCNTWHLEPTLRL | 4921 | Q2LD37 | |
| VERLFSLLSDCMWET | 1981 | Q15751 | |
| FCVRWALGLHVAEMS | 736 | Q9NRD8 | |
| DNMEFEQCIKLWLHA | 356 | Q9UK73 | |
| MDCTWRILFLVAAAT | 1 | A0A0C4DH33 | |
| ILQCWSDIMFEHFFL | 141 | P43629 | |
| FQECRAKEHMLRTNW | 181 | Q8N3Y1 | |
| AKDMLQLWCHASERE | 276 | A0A0J9YX94 | |
| WVLSAAHCQSRFMRV | 56 | Q9H2R5 | |
| FDSCLLQMWFIHTLQ | 96 | Q9UKL2 | |
| FDACLFQMWLIHSFQ | 96 | Q9H2C5 | |
| WVLLQNCHLGLEFME | 3961 | Q96JB1 | |
| LVFLDSHCEVNVMWL | 241 | Q8NCW6 | |
| MRFCLNTLQHEWFRV | 1111 | Q14678 | |
| AWVCTNDMFRLALHN | 111 | P61970 | |
| MYATIWLREHNRVCD | 286 | P35354 | |
| ALHQLMLDCWVRDRN | 866 | P54753 | |
| ILQCWSDVMFEHFLL | 46 | Q14952 | |
| AVSVLALWCNRFTME | 406 | Q92616 | |
| VDQCRHRLLMEFDIW | 691 | Q9HAQ2 | |
| AWTEEECRSFEHALM | 281 | Q7Z3K6 | |
| DECVEFHRLWSAMQF | 1146 | Q96F07 | |
| LDSHTCMLWRALAVE | 1141 | Q8NDA8 | |
| FSRLHCRNANEDWMS | 11 | Q9NUJ7 | |
| NFCRRPVHFELMSEW | 556 | P22557 | |
| IQSFRWFADLLCMLH | 466 | Q9NPH5 | |
| ILQCWSDVMFEHFLL | 46 | Q14953 | |
| CIFLVSASWIMNALH | 141 | P47890 | |
| DEMRRCHCELTWSQL | 346 | Q460N5 | |
| TVDFQDRLDCTAMHW | 206 | Q9GZV1 | |
| LAAMFCISNLIWNEE | 616 | Q8IUR7 | |
| VFLQNCHLAVSWMLA | 3596 | Q9C0G6 | |
| LQYLWEAHTNILRCM | 501 | Q05DH4 | |
| HDRLMQLADWDFSTL | 211 | A0A1W2PR19 | |
| EFSWRMCLVHFETVR | 166 | Q9H0H3 | |
| MLFNIHSLEWDKELC | 206 | Q14410 | |
| MLFNIHSLEWDKQLC | 206 | P32189 | |
| WAINACIDVMVHFDL | 286 | Q5T2N8 | |
| DWCRFSQMLHPIFEE | 56 | Q9BS26 | |
| IRDTLIHEMCHAASW | 586 | Q96QF7 | |
| LCAVDESNDHMLSVW | 176 | O95834 | |
| IWSLVDHALIARCNM | 351 | Q05BV3 | |
| LWSLADHALIARCNM | 351 | Q6ZMW3 | |
| EEAWRSHINQLMCDS | 2681 | Q5TBA9 | |
| FDSHEAMCAWDARIR | 91 | Q18PE1 | |
| ARMALWCATDHNVDN | 61 | Q5T4B2 | |
| AHQRQAAMRETALWC | 46 | Q08E93 | |
| MDELRWYHITVCLDH | 1 | Q0D2K5 | |
| ILQCWSDVMFEHFLL | 46 | P43626 | |
| ALWENVECNRHMLSR | 21 | Q9BXL7 | |
| TMYQDRHEWLCARVD | 806 | Q9BXL7 | |
| WALLQNCHLGLDFMD | 4096 | Q8TE73 | |
| DDRWMSQHNRFVLDC | 21 | P68402 | |
| DFEAAERHCMQLWRQ | 36 | O15294 | |
| MHQRLCFQLAAASWI | 136 | Q9GZK3 | |
| SDLIVCAWTAMEHIS | 186 | O14832 | |
| FVNVVWMSRLHFCDS | 156 | Q8NGG4 | |
| ILQCWSDVMFEHFLL | 46 | Q14954 | |
| IWFSMESPSNCRHLE | 146 | Q11128 | |
| DLQHMCLELTVWDRE | 591 | Q96C24 | |
| FDRAMEEWRQFHCDL | 1971 | P46939 | |
| QCRVQHLWFQSIFDM | 586 | Q9NRF2 | |
| CRMADQTFISIVDWA | 266 | Q13285 | |
| ISWHLASDMDCVVTL | 1741 | A6NHR9 | |
| SAACEWVVAMLLFAL | 181 | A6NC51 | |
| DWEIFALLRAELMCT | 426 | Q5SWL7 | |
| RWMRSCDHILYQALV | 441 | P48378 | |
| RLSHCIAESWMNFSI | 166 | Q9H6L5 | |
| LRTLELHSCEISMAW | 126 | Q9NXK8 | |
| ELNMCAQKRVAWHLF | 281 | Q9BQS7 | |
| ILQCWSDIMFEHFFL | 141 | Q14943 | |
| LERLRDVMCSYVWEH | 816 | O43147 | |
| AFLALFRLMTQDCWE | 361 | Q14524 | |
| SHMTSDRRQWCAIAI | 226 | O43752 | |
| RCSSMHFLVAEWNEP | 121 | P21673 | |
| AAWNELARACLHHME | 676 | Q8NEZ3 | |
| VHRWVNYESMLKECL | 111 | Q7L1T6 | |
| DRLAFSCIWEMNHNA | 556 | Q9Y2L1 | |
| LMHFCTSDVLSWNEV | 581 | Q6Q759 | |
| WVAQFLADMAALHAR | 836 | Q76KP1 | |
| WCERCVTLVQMNHAA | 536 | Q86XI2 | |
| WTMVIARACFDELQS | 176 | P29973 | |
| DNIHHWLLMDYLCDL | 686 | Q14028 | |
| LINNMWILTAAHCFR | 216 | O60235 | |
| LCRQMEHFLDSWKRF | 1676 | Q63HN8 | |
| HCLRCLRAWFASEQM | 4016 | Q63HN8 | |
| SCLCVHVRSEEWDLM | 6 | O15205 | |
| FEAAKLVMQWLCNHE | 446 | Q9C0D3 | |
| RLFLECDAHMWRLGD | 466 | Q86Y38 | |
| HWSNADILRLLECME | 16 | P0CB48 | |
| VAIRWLMLHTADSAC | 371 | Q12768 | |
| MHILSEETCFQRWLT | 426 | Q6NUQ1 | |
| QEMLRCIWGHFLRVL | 376 | Q12767 | |
| HMTSDRRQWCAIAVL | 221 | O60499 | |
| RWSCEHLIMVWINAF | 316 | Q9NV64 | |
| SLCRELHTLFRVMWS | 356 | Q70CQ1 | |
| LHQMCLQLWRDVIDS | 766 | Q8TBZ2 | |
| AFLHALWQDRRDSAM | 986 | Q5SRE5 | |
| NECVAQTWFRFLHML | 276 | Q86X10 | |
| WEIRMHCELFFNSFQ | 391 | P49190 | |
| ARSFCREHMQLFRWI | 71 | O00337 | |
| QRCLYHDVMLENWVL | 26 | Q8TF45 | |
| IEFSLEEWHCLDMAQ | 11 | Q6ZN08 | |
| EEWHCLDMAQRNLYR | 16 | Q6ZN08 | |
| RCESLLFNESMLWEN | 1106 | Q01118 | |
| EWMAQDLENIVAIHC | 306 | Q6XPS3 | |
| SCADVVWHQMDENLL | 76 | Q96S15 | |
| CIQARENHLFRWLMD | 211 | O15050 | |
| RFQQLVHQMTELCWE | 31 | O60220 | |
| WVITAAHCFQEDSMA | 611 | Q8IU80 | |
| HLMKNCWETEASFRP | 1146 | P29597 | |
| LRHWDENLEFNMLCY | 1201 | Q5TIE3 | |
| LSNILCWAFHMLVNA | 211 | Q8NFZ6 | |
| LRCFHQLMKDTTLNW | 161 | P23919 | |
| RFLMRVNESSWHEEC | 66 | O60663 | |
| IEMLERLWLSGICHN | 816 | O15399 |